Based on the analysis of Marex Group's profitability, liquidity, and operating efficiency, Marex Group plc may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter. At this time, Marex Group's Non Current Liabilities Other is fairly stable compared to the past year. Net Working Capital is likely to rise to about 1.3 B in 2025, whereas Total Assets are likely to drop slightly above 11.7 B in 2025. Key indicators impacting Marex Group's financial strength include:
The financial analysis of Marex Group is a critical element in measuring its lifeblood. Investors should not minimize Marex Group's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the imprecision that can be found in Marex Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Marex Group plc. Check Marex Group's Beneish M Score to see the likelihood of Marex Group's management manipulating its earnings.
Marex Group Stock Summary
Marex Group competes with Braskem SA, Ecovyst, Codexis, Solstad Offshore, and SBM Offshore. Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada.
Comparative valuation techniques use various fundamental indicators to help in determining Marex Group's current stock value. Our valuation model uses many indicators to compare Marex Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marex Group competition to find correlations between indicators driving Marex Group's intrinsic value. More Info.
Marex Group plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.05 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Marex Group plc is roughly 20.61 . At this time, Marex Group's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marex Group's earnings, one of the primary drivers of an investment's value.
Marex Group plc Systematic Risk
Marex Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Marex Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Marex Group plc correlated with the market. If Beta is less than 0 Marex Group generally moves in the opposite direction as compared to the market. If Marex Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Marex Group plc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Marex Group is generally in the same direction as the market. If Beta > 1 Marex Group moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Marex Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Marex Group's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Marex Group growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Marex Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Marex Group plc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Marex Group plc based on widely used predictive technical indicators. In general, we focus on analyzing Marex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Marex Group's daily price indicators and compare them against related drivers.
When running Marex Group's price analysis, check to measure Marex Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marex Group is operating at the current time. Most of Marex Group's value examination focuses on studying past and present price action to predict the probability of Marex Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marex Group's price. Additionally, you may evaluate how the addition of Marex Group to your portfolios can decrease your overall portfolio volatility.